Trial · NCT03044353
Adverse events152
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 152
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Constipation | Gastrointestinal disorders | Group 1: Cardiac TTR Amyloidosis (ATTR-CM) Participants | 3 | 6 | 5 |
| other | Constipation | Gastrointestinal disorders | Group 2: Post-chemotherapy AL Amyloidosis Participants | 1 | 1 | 1 |
| other | Dyspepsia | Gastrointestinal disorders | Group 1: Cardiac TTR Amyloidosis (ATTR-CM) Participants | 2 | 6 | 2 |
| other | Dyspepsia | Gastrointestinal disorders | Group 2: Post-chemotherapy AL Amyloidosis Participants | 0 | 1 | 0 |
| other | Abdominal discomfort | Gastrointestinal disorders | Group 1: Cardiac TTR Amyloidosis (ATTR-CM) Participants | 1 | 6 | 1 |
| other | Abdominal discomfort | Gastrointestinal disorders | Group 2: Post-chemotherapy AL Amyloidosis Participants | 0 | 1 | 0 |
| other | Diarrhoea | Gastrointestinal disorders | Group 1: Cardiac TTR Amyloidosis (ATTR-CM) Participants | 1 | 6 | 1 |
| other | Diarrhoea | Gastrointestinal disorders | Group 2: Post-chemotherapy AL Amyloidosis Participants | 0 | 1 | 0 |
| other | Dry mouth | Gastrointestinal disorders | Group 1: Cardiac TTR Amyloidosis (ATTR-CM) Participants | 1 | 6 | 1 |
| other | Dry mouth | Gastrointestinal disorders | Group 2: Post-chemotherapy AL Amyloidosis Participants | 0 | 1 | 0 |
| other | Rash erythematous | Skin and subcutaneous tissue disorders | Group 1: Cardiac TTR Amyloidosis (ATTR-CM) Participants | 3 | 6 | 3 |
| other | Rash erythematous | Skin and subcutaneous tissue disorders | Group 2: Post-chemotherapy AL Amyloidosis Participants | 0 | 1 | 0 |
| other | Dermatitis contact | Skin and subcutaneous tissue disorders | Group 1: Cardiac TTR Amyloidosis (ATTR-CM) Participants | 2 | 6 | 6 |
| other | Dermatitis contact | Skin and subcutaneous tissue disorders | Group 2: Post-chemotherapy AL Amyloidosis Participants | 0 | 1 | 0 |
| other | Rash maculo-papular | Skin and subcutaneous tissue disorders | Group 1: Cardiac TTR Amyloidosis (ATTR-CM) Participants | 2 | 6 | 3 |
| other | Rash maculo-papular | Skin and subcutaneous tissue disorders | Group 2: Post-chemotherapy AL Amyloidosis Participants | 0 | 1 | 0 |
| other | Acne | Skin and subcutaneous tissue disorders | Group 1: Cardiac TTR Amyloidosis (ATTR-CM) Participants | 1 | 6 | 1 |
| other | Acne | Skin and subcutaneous tissue disorders | Group 2: Post-chemotherapy AL Amyloidosis Participants | 0 | 1 | 0 |
| other | Dermal cyst | Skin and subcutaneous tissue disorders | Group 1: Cardiac TTR Amyloidosis (ATTR-CM) Participants | 0 | 6 | 0 |
| other | Dermal cyst | Skin and subcutaneous tissue disorders | Group 2: Post-chemotherapy AL Amyloidosis Participants | 1 | 1 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03044353/events